Common Contracts
14 similar Common Stock Purchase Warrant contracts by Clarient, Inc, SCOLR Pharma, Inc., National Storm Management Inc., others
COMMON STOCK PURCHASE WARRANT To Purchase 1,350,000 Shares of Common Stock of SCOLR Pharma, Inc.Common Stock Purchase Warrant • June 15th, 2012 • SCOLR Pharma, Inc. • In vitro & in vivo diagnostic substances
THIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, Taglich Brothers, Inc. (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date that is six (6) months from the date hereof, but not before, and on or before the close of business on the Termination Date (as defined below) but not thereafter, to subscribe for and purchase from SCOLR Pharma, Inc. a corporation incorporated in the State of Delaware (the “Company”), up to 1,350,000 shares (the “Warrant Shares”) of common stock of the Company (the “Common Stock”). The purchase price for each full share of Common Stock (the “Exercise Price”) under this Warrant shall be $0.0625, subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. As used herein “Termination Date” shall mean June 30, 2016. Capitalized
COMMON STOCK PURCHASE WARRANT To Purchase 1,195,200 Shares of Common Stock of SCOLR Pharma, Inc.Common Stock Purchase Warrant • July 7th, 2011 • SCOLR Pharma, Inc. • In vitro & in vivo diagnostic substances
THIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, Taglich Brothers, Inc. (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date that is six (6) months from the date hereof, but not before, and on or before the close of business on the Termination Date (as defined below) but not thereafter, to subscribe for and purchase from SCOLR Pharma, Inc. a corporation incorporated in the State of Delaware (the “Company”), up to 1,195,200 shares (the “Warrant Shares”) of common stock of the Company (the “Common Stock”). The purchase price for each full share of Common Stock (the “Exercise Price”) under this Warrant shall be $0.0625, subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. As used herein “Termination Date” shall mean June 30, 2016. Capitalized
EXHIBIT WCommon Stock Purchase Warrant • June 11th, 2010 • VizStar, Inc. • Books: publishing or publishing & printing
COMMON STOCK PURCHASE WARRANT To Purchase «number» Shares of Common Stock of XTRA-GOLD RESOURCES CORP.Common Stock Purchase Warrant • March 31st, 2010 • Xtra-Gold Resources Corp • Metal mining • Nevada
THIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, ____________________________ (the “Holder”), of «address», is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ___________________________ (the “Initial Exercise Date”) and up to __________ months from the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from XTRA-GOLD RESOURCES CORP., a corporation incorporated in the State of Nevada (the “Company”), up to the number of full shares indicated above (the “Warrant Shares”) of common stock of the Company (the “Common Stock”). The purchase price of each share of Common Stock (the “Exercise Price”) under this Warrant shall be US$ ______, subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. Capitalized terms used and not ot
COMMON STOCK PURCHASE WARRANT To Purchase [ ] Shares of Common Stock of SCOLR Pharma, Inc.Common Stock Purchase Warrant • March 24th, 2010 • SCOLR Pharma, Inc. • In vitro & in vivo diagnostic substances
THIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date that is six (6) months from the date hereof, but not before, and on or before the close of business on the Termination Date (as defined below) but not thereafter, to subscribe for and purchase from SCOLR Pharma, Inc. a corporation incorporated in the State of Delaware (the “Company”), up to [ ] shares (the “Warrant Shares”) of Common Stock, of the Company (the “Common Stock”). The purchase price of each full share of Common Stock (the “Exercise Price”) under this Warrant shall be SEVENTY FIVE CENTS ($0.75), subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. As used herein “Termination Date” shall mean March 12, 2015. Capitalized terms us
COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • March 2nd, 2009 • Clarient, Inc • Services-medical laboratories
THIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, Safeguard Delaware, Inc., a Delaware corporation (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [DATE OF ISSUANCE] (the “Initial Exercise Date”) and on or prior to the close of business on [FIVE YEAR ANNIVERSARY OF DATE OF ISSUANCE] (the “Termination Date”) but not thereafter, to subscribe for and purchase from Clarient, Inc., a corporation incorporated in the State of Delaware (the “Company”), up to ) shares (the “Warrant Shares”) of Common Stock, par value $0.01 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $ , and the Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein, provided however that in no event shall the Exercise Price
COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of SYNTHETIC BLOOD INTERNATIONAL, INC.Common Stock Purchase Warrant • September 22nd, 2008 • Oxygen Biotherapeutics, Inc. • Services-commercial physical & biological research • California
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) CERTIFIES that, for value received, FIONA International S.A., (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or prior to (the “Terminatior Date”) but not thereafter, to subscribe for and purchase from Synthetic Blood International, Inc., a New Jersey corporation (the “Company”), up to shares (the “Warrant Shares”) of Common Stock, par value $0.01 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant is $0.247. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein.
COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • March 17th, 2008 • Clarient, Inc • Laboratory analytical instruments
THIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, Safeguard Delaware, Inc., a Delaware corporation (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [DATE OF ISSUANCE] (the “Initial Exercise Date”) and on or prior to the close of business on [FIVE YEAR ANNIVERSARY OF DATE OF ISSUANCE] (the “Termination Date”) but not thereafter, to subscribe for and purchase from Clarient, Inc., a corporation incorporated in the State of Delaware (the “Company”), up to ( ) shares (the “Warrant Shares”) of Common Stock, par value $0.01 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $0.01, and the Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein, provided however that in no event shall the Exercise P
COMMON STOCK PURCHASE WARRANT Warrant No. -2006 To Purchase Shares of Common Stock of Avicena Group, Inc.Common Stock Purchase Warrant • December 1st, 2006 • Avicena Group, Inc. • Medicinal chemicals & botanical products
This Warrant is issued pursuant to that certain Securities Purchase Agreement, dated as of the date hereof, by and between the Company and the Purchaser identified therein.
COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • November 15th, 2006 • National Storm Management Inc. • General bldg contractors - residential bldgs
THIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, Nite Capital, L.P. (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth on or prior to the close of business on December 31, 2010 (the “Termination Date”) but not thereafter, to subscribe for and purchase from National Storm Management, Inc., a corporation incorporated in the State of Nevada (the “Company”), up to 1,000,000 shares (the “Warrant Shares”) of common stock, par value $0.001 per share, of the Company (the “Common: Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $[20], subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
COMMON STOCK PURCHASE WARRANT To Purchase (insert number of Shares) Shares of Common Stock of Neutron Enterprises, Inc.Common Stock Purchase Warrant • November 9th, 2006 • Neutron Enterprises Inc • Services-business services, nec
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) CERTIFIES that, for value received, [proper name] (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after _____, 2006 (the “Initial Exercise Date”) and on or prior to the close of business on October ______, 2008 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Neutron Enterprises, Inc., a corporation incorporated in the State of Nevada (the “Company”), up to [insert number] shares (the “Warrant Shares”) of Common Stock, par value $0.001 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $2.50, subject to adjustment hereunder. All references to dollars and “$” refer to the lawful currency of the United States.
COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • September 25th, 2006 • Clarient, Inc • Laboratory analytical instruments
THIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, Safeguard Delaware, Inc., a Delaware corporation (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after September 23, 2006 (the “Initial Exercise Date”) and on or prior to the close of business on September 23, 2010 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Clarient, Inc., a corporation incorporated in the State of Delaware (the “Company”), up to 624,306 shares (the “Warrant Shares”) of Common Stock, par value $0.01 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $0.98, subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. Capitalized terms used and not otherwise defin
COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • July 6th, 2006 • National Storm Management Inc.
THIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, Nite Capital, L.P. (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth on or prior to the close of business on December 31, 2010 (the “Termination Date”) but not thereafter, to subscribe for and purchase from National Storm Management, Inc., a corporation incorporated in the State of Nevada (the “Company”), up to 1,000,000 shares (the “Warrant Shares”) of common stock, par value $0.001 per share, of the Company (the “Common: Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $[20], subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
COMMON STOCK PURCHASE WARRANTCommon Stock Purchase Warrant • August 4th, 2005 • Chromavision Medical Systems Inc • Laboratory analytical instruments
THIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, Safeguard Delaware, Inc. (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August 1, 2005 (the “Initial Exercise Date”) and on or prior to the close of business on August 1, 2009 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Clarient, Inc., a corporation incorporated in the State of Delaware (the “Company”), up to fifty thousand (50,000) shares (the “Warrant Shares”) of Common Stock, par value $0.01 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $2.00. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein.
